Our Services
Medical Information
Helpful Resources
Published on: 3/11/2026
If you are still flaring on mesalamine, common reasons include disease that is too active for mesalamine alone, the wrong dose or formulation not reaching the inflamed area, drug intolerance, inconsistent use, overlapping issues like infection or IBS, or even a different diagnosis such as Crohn's.
There are several factors to consider. Next steps often include prompt discussion with your doctor, targeted labs and stool tests, optimizing or combining oral and rectal mesalamine, or stepping up to steroids, biologics, or small molecule therapies, with urgent care for red flags like high fever or heavy bleeding; see below for the complete guidance that can shape your personal plan.
If you're taking mesalamine and still experiencing flares, you're not alone. Mesalamine is a first-line treatment for mild to moderate ulcerative colitis (UC) and works well for many people. But it doesn't work for everyone — and sometimes, it can even seem to make symptoms worse.
Understanding why this happens can help you and your doctor decide what to do next.
Mesalamine (also called 5-aminosalicylic acid or 5-ASA) is an anti-inflammatory medication. It works directly in the lining of the colon to reduce inflammation.
Doctors commonly prescribe mesalamine to:
It comes in several forms:
When it works, it can significantly reduce inflammation and help keep UC under control. But if you're still flaring, there are several possible reasons.
Mesalamine is most effective for mild to moderate ulcerative colitis. If your inflammation is moderate to severe, mesalamine alone may not be strong enough.
Signs this may be the case include:
In these cases, stronger therapies such as corticosteroids, biologics, or small-molecule drugs may be necessary.
Different mesalamine formulations release medication in different parts of the colon.
For example:
If your disease location doesn't match the formulation, the medication may not be reaching the areas that need treatment.
This is a common and fixable issue. Adjusting the form or combining oral and rectal mesalamine often improves results.
Although mesalamine is generally well tolerated, some people develop intolerance. This can mimic a flare.
Possible signs of mesalamine intolerance include:
True allergic reactions are uncommon, but they do occur. In rare cases, mesalamine can worsen inflammation instead of calming it.
If symptoms began or intensified soon after starting mesalamine, your doctor may temporarily stop the medication to see if symptoms improve.
Mesalamine must be taken consistently to work.
Common issues include:
Ulcerative colitis is a chronic condition. Even when you feel better, inflammation can still be present at a microscopic level. Stopping mesalamine too soon increases the risk of relapse.
If adherence is difficult, talk with your doctor about simpler dosing options.
Sometimes symptoms persist because something else is happening.
Examples include:
Your doctor may order stool tests, blood work, or imaging to rule these out before escalating treatment.
In some cases, persistent symptoms prompt a reassessment of the diagnosis.
Other inflammatory bowel diseases (IBD), such as Crohn's disease, may not respond as well to mesalamine. Crohn's can affect deeper layers of the bowel and areas outside the colon.
If there's uncertainty about your diagnosis, your doctor may recommend:
If you're experiencing persistent symptoms and want to better understand what might be happening, you can check your symptoms using a free AI-powered Ulcerative Colitis symptom checker to help prepare questions for your next doctor's appointment.
If you're still flaring, don't panic — but don't ignore it either.
Here are practical next steps:
Persistent inflammation can lead to:
If you have:
Seek urgent medical care. These could signal a serious complication such as severe colitis.
Your doctor may:
Treatment decisions depend on disease severity, location, lab findings, and your overall health.
Your care team may order:
These help determine whether inflammation is ongoing or if something else is causing symptoms.
If mesalamine alone isn't enough, modern therapies are highly effective.
Options may include:
While these medications sound intimidating, they are well studied and have helped many patients achieve long-term remission.
Do not stop mesalamine without speaking to your doctor.
Abruptly stopping can:
If intolerance is suspected, your doctor will guide you through a safe adjustment.
Ulcerative colitis is a chronic immune-mediated condition. Treatment isn't just about symptom relief — it's about controlling inflammation and preventing long-term damage.
The goal today is:
If mesalamine achieves that, great. If not, that doesn't mean you've failed treatment — it just means your disease requires a different approach.
Call a doctor immediately if you experience:
These could indicate serious, potentially life-threatening complications like toxic megacolon or severe dehydration. They are uncommon, but they require urgent care.
If your gut seems to be "rejecting" mesalamine, there is usually a clear medical reason. It may be:
The important thing is not to ignore ongoing symptoms.
Ulcerative colitis is manageable — but only when inflammation is properly controlled. If you're still flaring, speak to a doctor. Adjustments in treatment can make a significant difference in your health, comfort, and long-term outcomes.
And if you're still trying to understand your symptoms, consider completing a free Ulcerative Colitis symptom assessment to prepare for your next medical conversation.
You deserve a treatment plan that works — and with the right guidance, you can find it.
(References)
* Kordasti, S., et al. (2019). Mechanisms underlying the anti-inflammatory properties of mesalazine in ulcerative colitis. *British Journal of Pharmacology*, *176*(3), 346–357. DOI: 10.1111/bph.14532
* Ungaro, R., et al. (2020). Treatment of Refractory Ulcerative Colitis: A Review. *Clinical Therapeutics*, *42*(7), 1279–1292. DOI: 10.1016/j.clinthera.2020.04.015
* Lam, J. Y., et al. (2019). Pharmacokinetics of Mesalamine and its Role in the Treatment of Inflammatory Bowel Disease. *Journal of Clinical Pharmacology*, *59*(1), 16–29. DOI: 10.1002/jcph.1299
* Singh, S., et al. (2020). Switching from 5-aminosalicylates to biologics in patients with ulcerative colitis: A systematic review and meta-analysis. *Gastroenterology*, *159*(5), 1803–1818.e11. DOI: 10.1053/j.gastro.2020.07.054
* Panaccione, R., et al. (2021). The Evolution of Treatment for Ulcerative Colitis: A Look at the Present and Future. *Journal of Crohn's and Colitis*, *15*(Supplement_2), S16–S23. DOI: 10.1093/ecco-jcc/jjab067
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.